NYSE:WST 23 October 2025 - 12 January 2026

ENDEDLive coverage has endedEnded: October 25, 2025, 6:00 AM EDT West Pharmaceutical Services Q3 Profit Beats Estimates, Raises FY25 Guidance (WST) October 23, 2025, 7:22 AM EDT. West Pharmaceutical Services (WST) reported a Q3 profit of $140.0 million, or $1.92 per share (GAAP), up from $136.0 million, $1.85 a year earlier. Excluding items, adjusted earnings rose to $142.4 million, or $1.96 per share, versus consensus of about $1.69. Revenue climbed 7.7% to $804.6 million from $746.9 million. Looking ahead, the company issued next-quarter guidance of $1.81-$1.86 for EPS and $790-$800 million for revenue. For FY25, West raised its adjusted-diluted EPS